AbbVie reports that its JAK inhibitor Rinvoq (upadacitinib) met primary and secondary endpoints in a pivotal Phase 3 study testing the drug in patient...
An in-depth ProPublica report details the effects of massive staffing cuts at FDA and other HHS agencies that experts say threaten to set back public ...
14 states join a petition submitted by four other states calling on FDA to eliminate the mifepristone REMS requirements in their states or exercise di...
FDA announces a 10/23 public workshop to discuss the regulatory status of, and potential alternatives to, patch tests used in diagnosing allergic cont...
Nucleus RadioPharma appoints former FDA commissioner Stephen Hahn (Trump Administration 2019-2021) as its chief executive officer.
FDA issues enVVeno Medical a not-approvable letter for its PMA on VenoValve, a surgical replacement venous valve designed to treat severe deep chronic...
FDA lifts a clinical hold on Rocket Pharmaceuticals pivotal Phase 2 trial of RP-A501, an investigational gene therapy for Danon disease.
Experts share varying opinions with Clinical Trials Arena on the impact of an FDA rule barring biotech companies from sending cells from U.S. patients...
